Kea Insight / Analyst Relations

Nucleus Research: What the Technology Value Matrix Means for Vendors

By Bram Weerts

Nucleus Research approaches enterprise technology through a question that is easy to ask and harder to answer: what measurable value does the software deliver?

For a technology vendor, that makes Nucleus relevant for reasons that go beyond a place in its Technology Value Matrix. The firm publishes assessments of competing products, but it also studies deployments, calculates return on investment and helps buyers test the financial case for a technology decision.

An AR programme should understand both sides of that work. A company may be visible in the right Value Matrix and still be unable to demonstrate the commercial benefits it promises.

This is the part where Kea can help: not by calculating a customer’s ROI for the analyst, but by identifying the relevant coverage, preparing product leaders for the right conversations, and making sure the team knows which deployment claims it can substantiate. Evidence belongs to the client; analyst preparation and follow-through can sit with us.

What Nucleus Research Focuses On

Nucleus Research describes itself as a provider of ROI-focused technology research and advisory services. Its coverage includes enterprise software and platforms across finance, ERP, HCM, supply chain, analytics, integration, customer-facing applications and other operating systems.

The research serves different purposes. Technology Value Matrices compare vendors within defined software markets; ROI case studies examine benefits realised in individual customer deployments. Nucleus also publishes value-focused research notes and guidebooks, while its vendor-services portfolio includes tools intended to support financial business cases. These are separate research products and should not be treated as a single evaluation process.

Those are not identical products. A buyer exploring whether to replace an ERP system needs a different discussion from a CFO checking whether a proposed investment will pay back. Nucleus’s research can be relevant to both, but through different evidence.

That is what AR should establish before putting the firm on a briefing calendar. Does Nucleus cover the market you sell into, and does its approach to product usability, functionality and measurable results match the questions your buyers are asking?

How the Technology Value Matrix Works

The Technology Value Matrix is Nucleus Research’s flagship comparative evaluation. It positions vendors within a specific software category using two principal dimensions: usability and functionality.

Functionality concerns what the software can do for users in the relevant market. Usability addresses how readily organisations can use those capabilities and realise value from them. Neither dimension is equivalent to a raw feature count or a vendor’s preferred marketing description.

Nucleus says its comparisons draw on actual end-user experiences. The matrix is relative, with its centre point reassessed at every publication. A vendor may therefore move even while improving its product if competitors progress faster. A Value Matrix is neither a product certification nor a guarantee that one provider is the best fit for all buyers.

Before interpreting the graphic, establish the exact edition, coverage and buyer problem. A Value Matrix for enterprise ERP is not a general ranking of every business application. A vendor may be a good option for a specific buyer and still sit outside the highest-positioned grouping.

How to Read the Four Categories

Nucleus’s published Value Matrix methodology defines four categories based on relative usability and functionality. Leaders score strongly on both dimensions. Experts offer deeper functionality that may require more training. Accelerators emphasise ease of use and faster adoption, often within a narrower scope. Core Providers deliver essential capabilities, potentially at a lower cost for buyers who need less functionality.

These are descriptions of a relative position in a particular category, not a universal order of merit. Nucleus explicitly notes that no single quadrant is the right answer for every buyer. A specialised buyer may value an Expert’s functional depth; a buyer prioritising rapid adoption may prefer a different trade-off. The assessment still has to be matched to the customer’s requirements and price expectations.

The trend arrow needs equal care. Nucleus describes it as an estimate of future relative direction, based on its assessment of vendor investment, roadmaps and customer expectations. It is not evidence that a future improvement has already been delivered. Cite the edition and market when discussing either the quadrant or its trend arrow.

The commercial question for a vendor is not simply “How do we become a Leader?” It is “Which customer problem are we solving, what evidence supports the capabilities being assessed and where does our product still create unnecessary work?”

Why ROI Evidence Matters Beyond the Matrix

The most distinctive part of Nucleus’s work is its emphasis on quantifying the value of technology deployments. Its ROI case studies examine customer costs, benefits and realised financial outcomes. Those reports serve a different purpose from a category comparison.

Consider a platform that claims to improve workforce planning. A feature demonstration may establish that the capability exists. A customer deployment can show whether planning took less time, how much manual work was reduced, which costs changed and what the customer invested to achieve those results.

The distinction matters to Sales as much as AR. A prospect may be comfortable with the product but need a defensible financial case for its CFO or procurement team. That is when observed results, baseline definitions and a clear calculation become commercially useful.

These numbers have limits. A return achieved by one customer does not automatically apply to another organisation with different processes, adoption and costs. Good evidence should make those assumptions visible, not hide them behind a large percentage.

Nucleus also publishes research and tools for technology buyers who are building or validating investment decisions. An AR programme that understands this audience can supply evidence more useful than another product launch presentation.

How Kea Helps a Vendor Prepare

A Value Matrix or ROI-focused briefing can expose a gap between a product claim and the proof available to support it. That is not a problem a longer presentation will solve. A Kea AR Workshop can bring Product, Marketing, Sales and customer-evidence owners together to test the story, decide which claims need proof and agree what can be presented to analysts now.

For teams already running AR, AR Support can help select the right analysts, prepare spokespeople, review the evidence against the research scope and organise follow-up. If the company needs the whole programme managed, that belongs with AR-as-a-Service. Kea does not audit the customer’s financial results or determine Nucleus Research’s independent evaluation; the client must verify its own deployment and ROI claims.

When a Technology Vendor Should Engage

First, check whether Nucleus publishes a Value Matrix in your actual category. Its research archive includes recent work on enterprise ERP, integration platforms, supply-chain technology, workforce planning and many other enterprise applications. Coverage changes, so the relevant edition and analyst need checking.

Second, ask whether your buyers use ROI evidence to make decisions. If your company sells into finance-led business cases, large implementations or software renewal discussions, Nucleus’s approach may offer a useful external test of the claims Sales already makes.

Third, separate analyst engagement from paid research services. Nucleus offers vendor advisory services, ROI case studies and other commercial products. Buying a service is a different decision from seeking informed, independent coverage. Do not assume a commercial relationship guarantees a Value Matrix result.

Where the research has little relevance to your market, keep the programme focused elsewhere. The objective is coverage among the analysts whose work can affect real customer decisions, not collecting as many research-firm names as possible.

What to Prepare Before a Briefing

Bring a concise account of the buyer problem, the category in which you compete and the capabilities you can demonstrate today. Explain how customers deploy and use the product, including the implementation effort required to reach value.

For value claims, prepare a documented baseline and a defined measurement period. Separate cost reduction, time saved, revenue effects and qualitative benefits. Identify the customer source and whether results are measured, estimated or still being validated.

In the briefing itself, allow the analyst to challenge the evidence. A product may be technically impressive but difficult to adopt; its promised savings may depend on changes outside the software. Those concerns are worth understanding before the next evaluation or buyer conversation.

Where there is no customer-approved financial evidence, do not invent it. Start by improving the underlying evidence programme. Our Insight A Customer Logo Is Not a Customer Proof Point explains why a familiar name without deployment details is rarely enough.

What Each Team Should Do

Founder or CEO: Decide whether the company can substantiate its central value proposition, not merely demonstrate the technology.
AR leader: Map relevant Value Matrix categories and analysts, prepare focused briefings and separate independent evaluation from commercial advisory or commissioned research.
Product leader: Validate functionality and usability claims, implementation requirements and the product changes most relevant to adoption.
Customer Success or Finance: Establish measurable deployment outcomes, baselines, evidence ownership and permissions for sharing customer data.
Sales or GTM: Learn which value evidence helps buyers make the business case; ask how independent research entered their evaluation.
Marketing: Check licensing and citation rights before using research externally, and avoid presenting case-study results as universal outcomes.

The Practical AR Decision

Nucleus Research can be relevant when your buyers care about the return on enterprise technology, the effort required to use it and the differences between competing solutions. Its Technology Value Matrix is one route into that conversation; ROI research and buyer advisory work are others.

The best preparation starts with verified customer outcomes and a product story the analyst can test. Without those foundations, neither a workshop nor a series of briefings will make the value claims stronger.

A useful Nucleus briefing should leave the analyst better informed about what the product does and what changes when a customer uses it. That is a stronger objective than pursuing a favourable quadrant position on its own.

Related Kea Insights

Put this into practice

Can you prove the value your product promises?

A Kea AR Workshop brings Product, Marketing and Sales together to test analyst readiness, identify evidence gaps and agree what needs doing before the next evaluation.

Explore AR Workshops

Not sure where to start? Take the eight-question AR Readiness Check.